287 related articles for article (PubMed ID: 35895157)
1. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
Singer W
Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.
Singer W; Schmeichel AM; Shahnawaz M; Schmelzer JD; Sletten DM; Gehrking TL; Gehrking JA; Olson AD; Suarez MD; Misra PP; Soto C; Low PA
Ann Neurol; 2021 Jun; 89(6):1212-1220. PubMed ID: 33881777
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing multiple system atrophy at the prodromal stage.
Xia C; Postuma RB
Clin Auton Res; 2020 Jun; 30(3):197-205. PubMed ID: 32232688
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
7. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
Leys F; Wenning GK; Fanciulli A
Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
[TBL] [Abstract][Full Text] [Related]
8. Predicting phenoconversion in pure autonomic failure.
Coon EA; Mandrekar JN; Berini SE; Benarroch EE; Sandroni P; Low PA; Singer W
Neurology; 2020 Aug; 95(7):e889-e897. PubMed ID: 32546656
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.
Singer W; Schmeichel AM; Shahnawaz M; Schmelzer JD; Boeve BF; Sletten DM; Gehrking TL; Gehrking JA; Olson AD; Savica R; Suarez MD; Soto C; Low PA
Ann Neurol; 2020 Sep; 88(3):503-512. PubMed ID: 32557811
[TBL] [Abstract][Full Text] [Related]
10. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
[TBL] [Abstract][Full Text] [Related]
11. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
[TBL] [Abstract][Full Text] [Related]
12. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.
Claassen DO; Josephs KA; Ahlskog JE; Silber MH; Tippmann-Peikert M; Boeve BF
Neurology; 2010 Aug; 75(6):494-9. PubMed ID: 20668263
[TBL] [Abstract][Full Text] [Related]
13. An overview on pure autonomic failure.
Pavy-Le Traon A; Foubert-Samier A; Fabbri M
Rev Neurol (Paris); 2024; 180(1-2):94-100. PubMed ID: 38129276
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder.
Fernandes M; Maio S; Eusebi P; Placidi F; Izzi F; Spanetta M; De Masi C; Lupo C; Calvello C; Nuccetelli M; Bernardini S; Mercuri NB; Liguori C
Sleep; 2024 Jan; 47(1):. PubMed ID: 37542734
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
[TBL] [Abstract][Full Text] [Related]
16. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.
Barone DA; Henchcliffe C
Clin Neurophysiol; 2018 Aug; 129(8):1551-1564. PubMed ID: 29883833
[TBL] [Abstract][Full Text] [Related]
17. [REM Sleep Behavior Disorder and α-synucleinopathy].
Miyamoto T; Numahata K; Ishido H; Miyamoto M
Brain Nerve; 2020 Feb; 72(2):107-117. PubMed ID: 32036336
[TBL] [Abstract][Full Text] [Related]
18. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
[TBL] [Abstract][Full Text] [Related]
19. CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD.
Liguori C; Paoletti FP; Placidi F; Ruffini R; Sancesario GM; Eusebi P; Mercuri NB; Parnetti L
Curr Neurol Neurosci Rep; 2019 Jan; 19(2):3. PubMed ID: 30637520
[TBL] [Abstract][Full Text] [Related]
20. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.
Goldstein DS; Isonaka R; Lamotte G; Kaufmann H
Clin Auton Res; 2021 Dec; 31(6):677-684. PubMed ID: 34669076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
